Application of Biomarkers in the Development of Drugs Intended for the Treatment of Osteoarthritis OARSI FDA Osteoarthritis Biomarkers Working Group
Application of Biomarkers in the Development of Drugs Intended for the Treatment of Osteoarthritis OARSI FDA Osteoarthritis Biomarkers Working Group
V. Kraus,B. Burnett,17 Authors,M. Todman
2011
245 Citations
TLDR
Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis and Cartilage, 19(5), 515-542.